-
Something wrong with this record ?
Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic
S. Skurtveit, B. Nechanská, M. Handal, M. Mahic, V. Mravčík, R. Gabrhelík,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
16-28157A
Ministry of Health of the Czech Republic - International
NV16-28157A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
CINAHL Plus with Full Text (EBSCOhost)
from 2003-03-01 to 1 year ago
Medline Complete (EBSCOhost)
from 1993-01-01 to 1 year ago
PubMed
30725515
DOI
10.1111/add.14576
Knihovny.cz E-resources
- MeSH
- Buprenorphine therapeutic use MeSH
- Length of Stay statistics & numerical data MeSH
- Adult MeSH
- Hospitalization statistics & numerical data MeSH
- Infections epidemiology MeSH
- Infant MeSH
- Pregnancy Complications drug therapy epidemiology MeSH
- Skin Diseases epidemiology MeSH
- Humans MeSH
- Methadone therapeutic use MeSH
- Young Adult MeSH
- Digestive System Diseases epidemiology MeSH
- Infant, Newborn MeSH
- Opiate Substitution Treatment statistics & numerical data MeSH
- Analgesics, Opioid therapeutic use MeSH
- Opioid-Related Disorders drug therapy epidemiology MeSH
- Child, Preschool MeSH
- Registries MeSH
- Case-Control Studies MeSH
- Pregnancy MeSH
- Prenatal Exposure Delayed Effects epidemiology MeSH
- Check Tag
- Adult MeSH
- Infant MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Infant, Newborn MeSH
- Child, Preschool MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND AND AIMS: Our understanding of the long-term safety of prenatal exposure to opioid maintenance treatment (OMT) is insufficient. We compared childhood morbidity (0-3 years) between OMT-exposed and relevant comparison groups. DESIGN: Nation-wide, registry-based cohort study. Registries on reproductive health, addiction treatment, hospitalization and death were linked using identification numbers. SETTING: The Czech Republic (2000-14). PARTICIPANTS: Children with different prenatal exposure: (i) mother in OMT during pregnancy (OMT; n = 218), (ii) mother discontinued OMT before pregnancy (OMT-D; n = 55), (iii) mother with opioid use disorder, but not in OMT during pregnancy (OUD; n = 85) and (iv) mother in the general population (GP) (n = 1 238 452) MEASUREMENTS: Episodes of hospitalization were observed as outcomes. Information on in-patient contacts, length of stay and diagnoses (International Classification of Diseases version 10) were assessed. Binary logistic regressions were conducted to estimate the associations between OMT exposure and the outcomes, crude and adjusted for the socio-economic status and smoking. FINDINGS: No significant differences were found in the overall proportion of hospitalization among OMT-exposed children, children of OMT-D and children of women with OUD [54.1%, 95% confidence interval (CI) = 47.3-60.1%; 47.3%, 95% CI = 33.9-61.1%; 51.8%, 95% CI = 40.7%-62.6%], while the proportion was significantly lower (35.8%, 95% CI = 35.7-35.8%) in the GP. There were no significant differences in risk of specific diagnoses between OMT-exposed children, children of OMT-D and children of women with OUD. In the adjusted analyses, differences between OMT-exposed and children in the GP were still present for infections and parasitic diseases (OR = 2.0, 95% CI = 1.4-2.7), diseases of the digestive system (OR = 1.7, 95% CI = 1.2-2.6) and diseases of the skin and subcutaneous tissue (OR = 1.9, 95% CI = 1.2-3.2). CONCLUSION: This study did not find clear evidence for an increase in risk of morbidity during the first 3 years of life in children with prenatal opioid maintenance treatment exposure compared with children of women who discontinued such treatment before pregnancy or suffered from opioid use disorder without this treatment. Compared the general population, there appears to be an increased risk of hospitalizations for infectious, gastrointestinal and skin diseases.
Department of Addictology 1st Faculty of Medicine Charles University Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025781
- 003
- CZ-PrNML
- 005
- 20201222154103.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/add.14576 $2 doi
- 035 __
- $a (PubMed)30725515
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Skurtveit, Svetlana $u Norwegian institute of Public Health, Oslo, Norway. Norwegian Centre for Addiction Research at the University of Oslo, Norway.
- 245 10
- $a Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic / $c S. Skurtveit, B. Nechanská, M. Handal, M. Mahic, V. Mravčík, R. Gabrhelík,
- 520 9_
- $a BACKGROUND AND AIMS: Our understanding of the long-term safety of prenatal exposure to opioid maintenance treatment (OMT) is insufficient. We compared childhood morbidity (0-3 years) between OMT-exposed and relevant comparison groups. DESIGN: Nation-wide, registry-based cohort study. Registries on reproductive health, addiction treatment, hospitalization and death were linked using identification numbers. SETTING: The Czech Republic (2000-14). PARTICIPANTS: Children with different prenatal exposure: (i) mother in OMT during pregnancy (OMT; n = 218), (ii) mother discontinued OMT before pregnancy (OMT-D; n = 55), (iii) mother with opioid use disorder, but not in OMT during pregnancy (OUD; n = 85) and (iv) mother in the general population (GP) (n = 1 238 452) MEASUREMENTS: Episodes of hospitalization were observed as outcomes. Information on in-patient contacts, length of stay and diagnoses (International Classification of Diseases version 10) were assessed. Binary logistic regressions were conducted to estimate the associations between OMT exposure and the outcomes, crude and adjusted for the socio-economic status and smoking. FINDINGS: No significant differences were found in the overall proportion of hospitalization among OMT-exposed children, children of OMT-D and children of women with OUD [54.1%, 95% confidence interval (CI) = 47.3-60.1%; 47.3%, 95% CI = 33.9-61.1%; 51.8%, 95% CI = 40.7%-62.6%], while the proportion was significantly lower (35.8%, 95% CI = 35.7-35.8%) in the GP. There were no significant differences in risk of specific diagnoses between OMT-exposed children, children of OMT-D and children of women with OUD. In the adjusted analyses, differences between OMT-exposed and children in the GP were still present for infections and parasitic diseases (OR = 2.0, 95% CI = 1.4-2.7), diseases of the digestive system (OR = 1.7, 95% CI = 1.2-2.6) and diseases of the skin and subcutaneous tissue (OR = 1.9, 95% CI = 1.2-3.2). CONCLUSION: This study did not find clear evidence for an increase in risk of morbidity during the first 3 years of life in children with prenatal opioid maintenance treatment exposure compared with children of women who discontinued such treatment before pregnancy or suffered from opioid use disorder without this treatment. Compared the general population, there appears to be an increased risk of hospitalizations for infectious, gastrointestinal and skin diseases.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a opioidní analgetika $x terapeutické užití $7 D000701
- 650 _2
- $a buprenorfin $x terapeutické užití $7 D002047
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a nemoci trávicího systému $x epidemiologie $7 D004066
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hospitalizace $x statistika a číselné údaje $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a infekce $x epidemiologie $7 D007239
- 650 _2
- $a délka pobytu $x statistika a číselné údaje $7 D007902
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methadon $x terapeutické užití $7 D008691
- 650 _2
- $a opiátová substituční terapie $x statistika a číselné údaje $7 D058850
- 650 _2
- $a poruchy spojené s užíváním opiátů $x farmakoterapie $x epidemiologie $7 D009293
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a komplikace těhotenství $x farmakoterapie $x epidemiologie $7 D011248
- 650 _2
- $a zpožděný efekt prenatální expozice $x epidemiologie $7 D011297
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a kožní nemoci $x epidemiologie $7 D012871
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nechanská, Blanka $u Department of Addictology, First Faculty of Medicine, Charles University, Czech Republic. Institute of Health Information and Statistics of the, Czech Republic.
- 700 1_
- $a Handal, Marte $u Norwegian institute of Public Health, Oslo, Norway.
- 700 1_
- $a Mahic, Milada $u Norwegian institute of Public Health, Oslo, Norway.
- 700 1_
- $a Mravčík, Viktor $u Department of Addictology, First Faculty of Medicine, Charles University, Czech Republic. National Monitoring Centre for Drugs and Addiction, Prague, Czech Republic.
- 700 1_
- $a Gabrhelík, Roman $u Department of Addictology, First Faculty of Medicine, Charles University, Czech Republic.
- 773 0_
- $w MED00000153 $t Addiction (Abingdon, England) $x 1360-0443 $g Roč. 114, č. 7 (2019), s. 1225-1235
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30725515 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222154059 $b ABA008
- 999 __
- $a ok $b bmc $g 1599926 $s 1116467
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 114 $c 7 $d 1225-1235 $e 20190312 $i 1360-0443 $m Addiction $n Addiction $x MED00000153
- GRA __
- $a 16-28157A $p Ministry of Health of the Czech Republic $2 International
- GRA __
- $a NV16-28157A $p MZ0
- LZP __
- $a Pubmed-20201125